mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.005 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.007 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.007 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |